Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer

NCT00056095 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00056095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
November 4, 2002
Completion date
August 17, 2016
Enrollment
57 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer